Breaking barriers in cancer treatment: nanobiohybrids empowered by modified bacteria and vesicles

Author:

Ijaz Muhammad12,Khurshid Mohsin2ORCID,Gu Jingsi3,Hasan Ikram4,Roy Shubham1ORCID,Ullah Zia1,Liang Simin5,Cheng Jing3,Zhang Yinghe1,Mi Chao67,Guo Bing1ORCID

Affiliation:

1. School of Science, Shenzhen Key Laboratory of Flexible Printed Electronics Technology, Shenzhen Key Laboratory of Advanced Functional Carbon Materials Research and Comprehensive Application, Harbin Institute of Technology, Shenzhen-518055, China

2. Institute of Microbiology, Government College University, Faisalabad, Pakistan

3. Education Center and Experiments and Innovations, Harbin Institute of Technology, Shenzhen 518055, China

4. School of Biomedical Engineering, Medical School, Shenzhen University, Shenzhen, Guangdong, 518060, China

5. Department of Medical Ultrasonic, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China

6. Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, China

7. Shenzhen Light Life Technology Co., Ltd, Shenzhen, 518107, China

Abstract

The progress in nanobiohybrids empowered by modified bacteria and vesicles for cancer treatment is systematically updated.

Funder

Ministry of Education of the People's Republic of China

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Shenzhen Science and Technology Innovation Commission

Publisher

Royal Society of Chemistry (RSC)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3